Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABA A Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys
In nonhuman primates we tested a new set of behavioral categories for observable sedative effects using pediatric anesthesiology classifications as a basis. Using quantitative behavioral observation techniques in rhesus monkeys, we examined the effects of alprazolam and diazepam (nonselective benzod...
Saved in:
Published in | The Journal of pharmacology and experimental therapeutics Vol. 366; no. 1; p. 145 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.07.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In nonhuman primates we tested a new set of behavioral categories for observable sedative effects using pediatric anesthesiology classifications as a basis. Using quantitative behavioral observation techniques in rhesus monkeys, we examined the effects of alprazolam and diazepam (nonselective benzodiazepines), zolpidem (preferential binding to
1 subunit-containing GABA
receptors), HZ-166 (8-ethynyl-6-(2'-pyridine)-4
-2,5,10b-triaza-benzo[
]azulene-3-carboxylic acid ethyl ester; functionally selective with relatively high intrinsic efficacy for
2 and
3 subunit-containing GABA
receptors), MRK-696 [7-cyclobutyl-6-(2-methyl-2
-1,2,4-triazol-2-ylmethoxy)-3-(2-flurophenyl)-1,2,4-triazolo(4,3-
)pyridazine; no selectivity but partial intrinsic activity], and TPA023B 6,2'-diflouro-5'-[3-(1-hydroxy-1-methylethyl)imidazo[1,2-
][1,2,4]triazin-7-yl]biphenyl-2-carbonitrile; partial intrinsic efficacy and selectivity for
2,
3,
5 subunit-containing GABA
receptors]. We further examined the role of
1 subunit-containing GABA
receptors in benzodiazepine-induced sedative effects by pretreating animals with the
1 subunit-preferring antagonist
-carboline-3-carboxylate-
-butyl ester (
CCT). Increasing doses of alprazolam and diazepam resulted in the emergence of observable ataxia, rest/sleep posture, and moderate and deep sedation. In contrast, zolpidem engendered dose-dependent observable ataxia and deep sedation but not rest/sleep posture or moderate sedation, and HZ-166 and TPA023 induced primarily rest/sleep posture. MRK-696 induced rest/sleep posture and observable ataxia. Zolpidem, but no other compounds, significantly increased tactile/oral exploration. The sedative effects engendered by alprazolam, diazepam, and zolpidem generally were attenuated by
CCT pretreatments, whereas rest/sleep posture and suppression of tactile/oral exploration were insensitive to
CCT administration. These data suggest that
2/3-containing GABA
receptor subtypes unexpectedly may mediate a mild form of sedation (rest/sleep posture), whereas
1-containing GABA
receptors may play a role in moderate/deep sedation. |
---|---|
AbstractList | In nonhuman primates we tested a new set of behavioral categories for observable sedative effects using pediatric anesthesiology classifications as a basis. Using quantitative behavioral observation techniques in rhesus monkeys, we examined the effects of alprazolam and diazepam (nonselective benzodiazepines), zolpidem (preferential binding to
1 subunit-containing GABA
receptors), HZ-166 (8-ethynyl-6-(2'-pyridine)-4
-2,5,10b-triaza-benzo[
]azulene-3-carboxylic acid ethyl ester; functionally selective with relatively high intrinsic efficacy for
2 and
3 subunit-containing GABA
receptors), MRK-696 [7-cyclobutyl-6-(2-methyl-2
-1,2,4-triazol-2-ylmethoxy)-3-(2-flurophenyl)-1,2,4-triazolo(4,3-
)pyridazine; no selectivity but partial intrinsic activity], and TPA023B 6,2'-diflouro-5'-[3-(1-hydroxy-1-methylethyl)imidazo[1,2-
][1,2,4]triazin-7-yl]biphenyl-2-carbonitrile; partial intrinsic efficacy and selectivity for
2,
3,
5 subunit-containing GABA
receptors]. We further examined the role of
1 subunit-containing GABA
receptors in benzodiazepine-induced sedative effects by pretreating animals with the
1 subunit-preferring antagonist
-carboline-3-carboxylate-
-butyl ester (
CCT). Increasing doses of alprazolam and diazepam resulted in the emergence of observable ataxia, rest/sleep posture, and moderate and deep sedation. In contrast, zolpidem engendered dose-dependent observable ataxia and deep sedation but not rest/sleep posture or moderate sedation, and HZ-166 and TPA023 induced primarily rest/sleep posture. MRK-696 induced rest/sleep posture and observable ataxia. Zolpidem, but no other compounds, significantly increased tactile/oral exploration. The sedative effects engendered by alprazolam, diazepam, and zolpidem generally were attenuated by
CCT pretreatments, whereas rest/sleep posture and suppression of tactile/oral exploration were insensitive to
CCT administration. These data suggest that
2/3-containing GABA
receptor subtypes unexpectedly may mediate a mild form of sedation (rest/sleep posture), whereas
1-containing GABA
receptors may play a role in moderate/deep sedation. |
Author | Dawson, Gerard R Platt, Donna M Stephen, Michael Rajesh Meng, Zhiqiang Atack, John R Reynolds, David S Tiruveedhula, V V N Phani Babu Cook, James M Rowlett, James K Li, Guanguan Sieghart, Werner Duke, Angela N |
Author_xml | – sequence: 1 givenname: Angela N surname: Duke fullname: Duke, Angela N organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) – sequence: 2 givenname: Zhiqiang surname: Meng fullname: Meng, Zhiqiang organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) – sequence: 3 givenname: Donna M surname: Platt fullname: Platt, Donna M organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) – sequence: 4 givenname: John R surname: Atack fullname: Atack, John R organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) – sequence: 5 givenname: Gerard R surname: Dawson fullname: Dawson, Gerard R organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) – sequence: 6 givenname: David S surname: Reynolds fullname: Reynolds, David S organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) – sequence: 7 givenname: V V N Phani Babu surname: Tiruveedhula fullname: Tiruveedhula, V V N Phani Babu organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) – sequence: 8 givenname: Guanguan surname: Li fullname: Li, Guanguan organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) – sequence: 9 givenname: Michael Rajesh surname: Stephen fullname: Stephen, Michael Rajesh organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) – sequence: 10 givenname: Werner surname: Sieghart fullname: Sieghart, Werner organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) – sequence: 11 givenname: James M surname: Cook fullname: Cook, James M organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) – sequence: 12 givenname: James K surname: Rowlett fullname: Rowlett, James K email: jrowlett@umc.edu organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) jrowlett@umc.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29720564$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kMtOAjEYhRujkYuu3Zm-ANjbXOpuMIgkGCLgmnQ6f0MROpNpZyK8hW_sJOjqnOR8-RZngK5d6QChB0rGlDLxtK8gdC0dMyFZRK5Qn0aMjgglvIcG3u8JoULE_Bb1mEwYiWLRRz_T1hbgNODNTgW8hkIF2wKeGgM6eFwaPAF3LgurzlBZBx7PXVseOuTTwXfVQVDgWTbJcIZXoKEKZY3XTR5OFfhn_NEoF2y4SJe5h7rteunwOjSF7WzW4dUOfOPxe-m-4OTv0I1RBw_3fzlEm9fp5uVttFjO5i_ZYlRJHkYGjEwSzlIVS5XGQppcaw3cEKZ4IpQiRlPWzXmRmBwKJhKeSAEyZTqKTcyH6PGirZr8CMW2qu1R1aft_zX8F_3CaaY |
ContentType | Journal Article |
Copyright | Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics. |
Copyright_xml | – notice: Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1124/jpet.118.249250 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1521-0103 |
ExternalDocumentID | 29720564 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDA NIH HHS grantid: R01 DA033795 – fundername: NCRR NIH HHS grantid: K26 RR000168 – fundername: NIDA NIH HHS grantid: R01 DA011792 – fundername: NCRR NIH HHS grantid: P51 RR000168 – fundername: NIDA NIH HHS grantid: R01 DA043204 – fundername: NINDS NIH HHS grantid: R01 NS076517 – fundername: NIAAA NIH HHS grantid: R01 AA016179 |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 2WC 3O- 4.4 53G 5GY 5RE 5VS 8WZ A6W AALRI AAXUO AAYOK ABCQX ABIVO ABJNI ABOCM ABSQV ACGFO ACGFS ACNCT ADBBV ADCOW ADIYS AENEX AERNN AETEA AFFNX AFOSN AGFXO AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD F5P F9R FDB GX1 H13 HZ~ INIJC KQ8 L7B LSO M41 MJL MVM NPM O9- OHT P2P R.V R0Z RHI ROL RPT TR2 UQL VH1 W8F WH7 WOQ X7M YBU YHG YQT ZGI ZXP |
ID | FETCH-LOGICAL-p93t-fef977328a69a8649fbccce3f02a374aa0fc1228abd7fbed2473794e982c56f63 |
IngestDate | Sat Mar 08 01:25:24 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p93t-fef977328a69a8649fbccce3f02a374aa0fc1228abd7fbed2473794e982c56f63 |
PMID | 29720564 |
ParticipantIDs | pubmed_primary_29720564 |
PublicationCentury | 2000 |
PublicationDate | 2018-07-00 |
PublicationDateYYYYMMDD | 2018-07-01 |
PublicationDate_xml | – month: 07 year: 2018 text: 2018-07-00 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of pharmacology and experimental therapeutics |
PublicationTitleAlternate | J Pharmacol Exp Ther |
PublicationYear | 2018 |
SSID | ssj0014463 |
Score | 2.369033 |
Snippet | In nonhuman primates we tested a new set of behavioral categories for observable sedative effects using pediatric anesthesiology classifications as a basis.... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 145 |
SubjectTerms | Animals Behavior, Animal - drug effects Benzodiazepines - pharmacology Female Hypnotics and Sedatives - pharmacology Macaca mulatta Male Receptors, GABA-A - metabolism |
Title | Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABA A Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29720564 |
Volume | 366 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWGsmGDeD8K6C5QNzRlxs4kDrsUChUIaEuQuqsc22EqtUlgEiTmL_gdvo5747w6gARsoihWHCnn6L58H4w9RhUnpA45kpcHni9T4ykTICBSziOj5UxLKnB--y7Y_-i_Pp4fTyY_RllLdZXu6NVv60r-B1V8hrhSlew_INtvig_wHvHFKyKM17_CuBsJ-iRZoJ__wRrXxXtvyNHYtfmqQAqsbEn57dRWozj7SqYmtfbXZG6-inepOB3tR1uiA06ihOKyTarcYa3ypgqNtn2f9hHcLv2QoiVHC7uslyQcUB4sx8buUHbWGLzl0CXbNX26MF1gVAg2zLqvXepQTJm3ajg1olTc5lRlcfoZ6f2pl-9nyp11vSjyXA2B3rhSTuo3eUJH40jHTPZZsaioWunMKfYxFWPxLdzUlgs8dcJ45hpV_qokuE9KAr0SvJc71DPRNb8dUaY8bzjDo5CjiegP2rLPYeyWLrHLHF0Ump7x5nA4wUI3W7StpPB7T9e-Rj2o2_fX_JnGrkmusastPhA7dl1nE5vfYFsHDqtv25CMcNmGLTgYoXiTfe8oCERB6CgILQWhyGCNgtBSEAYKAlEQYugoCB0Fn8GYgDAiILQEhNMcHAGhJeAtlrzcS57ve-2UD6-MROVlNkMXRHCpgkjJwI-yVGttRTblSoS-UtNMzzgupybMUmu4HwrUITaSXM-DLBC32UZe5PYug1AYK20qjJkaP0il0jRFRvoi9XmI299jd9yfPildJ5eTDoP7f1zZZFcGKj5gG9WX2j5EM7RKHzV4_wRioJAP |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+That+Sedative+Effects+of+Benzodiazepines+Involve+Unexpected+GABA+A+Receptor+Subtypes%3A+Quantitative+Observation+Studies+in+Rhesus+Monkeys&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Duke%2C+Angela+N&rft.au=Meng%2C+Zhiqiang&rft.au=Platt%2C+Donna+M&rft.au=Atack%2C+John+R&rft.date=2018-07-01&rft.eissn=1521-0103&rft.volume=366&rft.issue=1&rft.spage=145&rft_id=info:doi/10.1124%2Fjpet.118.249250&rft_id=info%3Apmid%2F29720564&rft.externalDocID=29720564 |